IDDI Speaker at the Precision Medicine and Health Technology Assessment Webinar
June 28, 2021
TOPICS OF THE PRECISION MEDICINE AND HTA ASSESSMENT WEBINAR
Precision medicine aims to tailor disease prevention, diagnosis and treatment to the individual patient, based on their individual features.
Health Technology Assessment (HTA) is an instrumental part of the process in obtaining reimbursement and market access for pharmaceuticals and medical products in countries around the world.
Marc Buyse ScD, CSO IDDI will speak about ‘Net benefit and correlation between benefit and harms’.
This scientific meeting will be hosted by The Basel Biometric Society (BBS) and the European Federation of Statisticians in the Pharmaceutical Industry (EFSPI).